Every year, half a million people suffer spinal cord injury
These patients are normally aged between 25 and 45 years old, and end unable to work, with estimated healthcare costs and value loss of 3M€
We can change that with NeoSpinnae
the novel implantable biomaterial that promotes sensory and motor recovery following spinal cord injury.
The beneficiaries are spinal cord injury patients
the business model is based on supplying the device to healthcare providers, such as hospitals, clinics, and national health services.
Made possible by:
Stay up to date
Things are moving fast and we would like to keep you up to date with our progress. Sign up to stay in the loop.